Holen Sie sich die Stockscreener-App
4.2039
0.93%
-0.0861
Schlusskurs vom Vortag:
$4.29
Offen:
$4.27
24-Stunden-Volumen:
139.29K
Relative Volume:
0.02
Marktkapitalisierung:
$2.23B
Einnahmen:
$2.21B
Nettoeinkommen (Verlust:
$-56.94M
KGV:
-37.40
EPS:
-0.1124
Netto-Cashflow:
$54.54M
1W Leistung:
-1.16%
1M Leistung:
-10.71%
6M Leistung:
+112.50%
1J Leistung:
+47.06%
1-Tages-Spanne:
$4.195
$4.29
1-Wochen-Bereich:
$4.12
$4.3695
52-Wochen-Spanne:
$1.58
$5.59
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
4.20 | 2.28B | 2.21B | -56.94M | 54.54M | -0.1124 |
UNH
Unitedhealth Group Inc
|
392.83 | 359.79B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
94.71 | 122.87B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
399.24 | 87.17B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
275.92 | 72.89B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
402.04 | 48.40B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Clover Health (NASDAQ:CLOV): Could Rates Set the Tone After Labor Day? - kalkinemedia.com
Bank of New York Mellon Corp Acquires New Shares in Clover Health Investments, Corp. $CLOV - MarketBeat
Clover Health (CLOV) Turns Profitable As Medicare Membership Explodes - Yahoo Finance
Clover Health Investments (NASDAQ:CLOV) Trading 4.7% HigherHere's Why - MarketBeat
Clover Health (NASDAQ: CLOV) officer who sold 474K shares plans more - Stock Titan
Clover Health to Participate in Upcoming Investor Conferences - The Manila Times
Clover Health Stock Stands Out Among Financially Fit Penny Stocks - Yahoo Finance
Clover Health Investments Corp. Class A (CLOV) Peer Comparison – Compare with Others - Value Research
Clover Health Is A 'Buy' Because Of Its AI (NASDAQ:CLOV) - Seeking Alpha
Clover Health Investments, Corp. (NASDAQ:CLOV) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Clover Health (CLOV) Q2 2026 Earnings Call Transcript - AOL.com
Clover Health Highlights CA Cohort Maturation Growth and 4.5-Star 2027 Impact - Minichart
Clover Health Highlights Depth-Focused Strategy and Technology Investments - TipRanks
Clover Health Investments : 2Q26 Supplemental Q&A - marketscreener.com
Clover publishes Q2 2026 supplemental Q&A highlighting Clover Assistant impact and strategy - TradingView
Health Insurance Providers Stocks Q2 Teardown: Clover Health (NASDAQ:CLOV) Vs The Rest - Barchart.com
Are These Penny Stocks Worth Watching? MSB, CLOV and HYLN - Kalkine Media
Clover Health's High Valuation Ignores Low-Margin Structural Realities (NASDAQ:CLOV) - Seeking Alpha
Q2 2026 Clover Health Investments Corp Earnings Call Transcript - GuruFocus
Q1 2026 Clover Health Investments Corp Earnings Call Transcript - GuruFocus
Clover Health interim CFO Thornton sells $78,032 in shares By Investing.com - Investing.com South Africa
Clover Health interim CFO Thornton sells $78,032 in shares - Investing.com
Clover Health (NASDAQ: CLOV) CFO’s tax sale covers RSU vesting - Stock Titan
Clover Health (NASDAQ: CLOV) notes $21K 10b5-1 sale by Thornton - Stock Titan
Clover Health Investments (NASDAQ:CLOV) Trading Down 5.7%Time to Sell? - MarketBeat
Clover Health (CLOV) Rises 2.45% to $4.60 as Momentum Builds Toward ResistanceSmart Beta Flow - Vinanet
Clover Health Investments (NASDAQ:CLOV) Cut to Buy at Wall Street Zen - MarketBeat
Clover Health Investments, Corp. • Robinhood Token Price, CLOV Price, Live Charts, and Marketcap - Coinbase
Clover Health Investments: Real Turnaround, But Already Priced In (NASDAQ:CLOV) - Seeking Alpha
Shareholder in CLOV (CLOV) registers 474,801 shares for potential sale - Stock Titan
Is Clover Health Investments (CLOV) Fairly Valued After A 228% Run? - Yahoo Finance
Clover Health Is Proving Its Profit Model (NASDAQ:CLOV) - Seeking Alpha
Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV? - Yahoo Finance
The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call - Yahoo Finance
Clover Health Investments, Corp. • Robinhood Token (CLOV) Price Prediction for 2026 to 2031 - Bybit
Clover Health Investments, Corp. (CLOV) Presents at Canaccord Genuity's 46th Annual Growth ConferenceSlideshow - Seeking Alpha
About Clover Health Investments, Corp. • Robinhood Token - Coinbase
Clover Health Interim CFO Joseph Clay Thornton Awarded 54,347 RSUs with Four-Year Vesting - Kalkine Media
Clover Health (CLOV) Slips 1.54% to $4.47 as Support at $4.25 Comes into FocusMomentum ETF - Vinanet
Clover Health Investments, Corp. • Robinhood Token (CLOV) Price, MarketCap, Charts and Fundamentals Info - BeInCrypto
Clover Health (CLOV) Climbs 3.4% to $4.54 as Attention Turns to $4.77 ResistanceNew Highs New Lows - Vinanet
Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth - MarketBeat
Clover Health Investments (NASDAQ:CLOV) Shares Down 4.7% After Insider Selling - MarketBeat
Clover Health at Canaccord Genuity conference: growth meets profit - Investing.com
Clover Health CEO Andrew Toy sells $408,260 in stock By Investing.com - Investing.com Canada
Clover Health CEO Andrew Toy sells $408,260 in stock - Investing.com
Clover Health Investments (NASDAQ:CLOV) CEO Andrew Toy Sells 87,798 Shares - MarketBeat
Clover Health (CLOV) CEO Andrew Toy sells 87,798 shares for tax withholding - Stock Titan
CLOV (Nasdaq: CLOV) discloses planned 85,704-share sale by Andrew Toy - Stock Titan
Clover Health releases transcript of Q2 2026 earnings call - Bitget
Clover Health Investments : 2Q26 Earnings Call Transcript - marketscreener.com
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):